Headlines

The 2023 VIPBG Excellence Awards Announced

The Virginia Institute for Psychiatric and Behavioral Genetics pre- and post-doc awards were announced on December 14, 2023. Annually since 2007, one predoctoral and one postdoctoral trainee are selected to receive the awards. The process requires VIPBG faculty members to first nominate exceptional trainees. The final recipients are selected after a faculty discussion and vote. These awards consist of a certificate of recognition in addition to a $500.00 gift.

This year, the awardees include Mallory Stephenson, M.S., who received the ...

Continue reading →
0

VCU’s Kenneth Kendler achieves No. 1 lifetime ranking among published psychiatry scholars

Kenneth Kendler, M.D., doesn’t love attention — he says he finds it “a little embarrassing.” But as a world-renowned researcher from his pioneering studies in psychiatric genetics, the Virginia Commonwealth University professor has continued to rake in the accolades throughout his decades-long career. The latest speaks to his legacy.

Kendler has long been among the top five most-cited researchers in the field, and in September 2023, he achieved the No. 1 lifetime ranking from ScholarGPS, which analyzes researchers and their publications ...

Continue reading →
0

VIPBG Faculty Receive Funding to Study AUD and PTSD Through NIAAA R01 Grant

Drs. Ananda Amstadter (VCU) and Abigail Lott (Emory) were recently funded to study models of comorbidity between alcohol use disorder (AUD) and post traumatic stress disorder (GTP) through a new NIAAA R01 (AA030549). They are joined by Co-Is from VCU (Drs. Sheerin and Bacanu), Emory (Drs. Micholopous, Ressler), SUNY (Dr. Peterson), and University of Windsor (Dr. Rappaport). AUD and PTSD commonly co-occur.

Directional models of comorbidity exist, self-medication ...

Continue reading →
0

Drs. Elizabeth Prom-Wormley and Hermine Maes Receive Funding for Their Resist! Project

Drs.Elizabeth Prom-Wormley and Hermine Maes recently received funding for their Resist! Project (R01 DA054313). The goal of this project is to index individual resistance to psychoactive substance use (SU) during adolescence and use the indices to identify factors influencing resistance into early middle adulthood, with a special focus on potentially modifiable factors.

We will also use a concept mapping approach to identify novel factors and a genetically-informed study design to account for genetic confounding. This project addresses ...

Continue reading →
0

Evaluating the role of common risk variation in the recurrence risk of schizophrenia in multiplex schizophrenia families

Schizophrenia (SCZ) is a severe, clinically heterogeneous psychiatric disorder with a population prevalence of ~1% [1]. Twin, family, and adoption studies consistently show a strong genetic component, with heritability estimates of around 0.75–0.80 [2,3,4,5,6], and family history (FH) remains the strongest risk factor for developing SCZ [7]. Despite high heritability, ~2/3 of SCZ cases report no FH of psychotic illness, and most subjects with a positive FH (FH+) report only a single affected relative [8, 9], concordant with the rates ...

Continue reading →
0

Genome-wide analysis of schizophrenia and multiple sclerosis identifies shared genomic loci with mixed direction of effects

In the last decade, genome-wide association studies (GWAS) have identified a large number of common genetic risk variants associated with complex human phenotypes (Visscher et al., 2017). Many genetic variants identified by GWAS exhibit varying degrees of genetic pleiotropy (Solovieff et al., 2013), and investigating the nature of these shared genetic risks is important for improving our understanding of the etiology and underlying genetic architecture of complex human disorders. A widely used method for assessing the genetic relationship between two ...

Continue reading →
0

CILSE doctoral candidate awarded NIH/NIDA grant

Daniel Bustamante, a Ph.D. candidate in VCU Integrative Life Sciences doctoral program with a concentration on Behavioral & Statistical Genetics, was awarded a National Institute of Health/National Institute on Drug Abuse (NIH/NIDA) F31 grant.

Bustamante is the Principle Investigator studying the risk for developing posttraumatic stress disorder (PTSD) and substance abuse disorder (SUD) as a result of traumatic experiences during childhood and early adolescence. The project, titled “Longitudinal neuroimaging and statistical genetics modeling of substance use and trauma-related phenotypes,” will study ...

Continue reading →
0

The 2021 VIPBG Excellence Awards Announced

The Virginia Institute for Psychiatric and Behavioral Genetics pre- and post-doc awards were announced on December 16, 2021. Annually since 2007, one predoctoral and one postdoctoral trainee are selected to receive the awards. The process requires VIPBG faculty members to first nominate exceptional trainees. The final recipients are selected after a faculty discussion and vote. These awards consist of a certificate of recognition in addition to a $500.00 gift.

This year, the awardees include Terrell Hicks, who received the ...

Continue reading →
0

Postdoctoral Training in Psychiatric and Statistical Genetics

The Virginia Institute for Psychiatric and Behavioral Genetics is pleased to invite applications for postdoctoral training with a focus on mental health. The Institute offers a rich interdisciplinary training environment. Institute faculty include leaders in the fields of behavioral and psychiatric genetics and represent a wide range of scientific backgrounds from molecular and statistical genetics to epidemiology, psychology, and psychiatry.

Currently funded research at VIPBG includes molecular-genetic studies of schizophrenia, major depression, anxiety and panic disorders, PTSD, substance use disorders ...

Continue reading →
0